Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
8.94
-0.29 (-3.14%)
At close: Feb 13, 2026, 4:00 PM EST
8.95
+0.01 (0.11%)
After-hours: Feb 13, 2026, 4:04 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $174.77 million as of February 13, 2026.
Market Cap
174.77M
Enterprise Value
177.49M
1-Year Change
n/a
Ranking
Category
Stock Price
$8.94
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $174.77M, a decrease of -43.40%. That is a compound annual growth rate of -57.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 174.77M | -24.62% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 184.86M |
| Prelude Therapeutics | 183.75M |
| SAB Biotherapeutics | 183.29M |
| C4 Therapeutics | 183.17M |
| Galectin Therapeutics | 177.94M |
| Tiziana Life Sciences | 177.40M |
| Tharimmune | 177.09M |
| Milestone Pharmaceuticals | 172.69M |